(CMR) Alberta, Canada, has reported its first death of a patient from a rare blood clot condition after receiving the AstraZeneca COVID-19 vaccine in the Province.
The patient is a woman in her 50s and is the only reported death so far in the province and the second death reported in the country. According to Reuters reports, Alberta's chief medical officer of health, Dr. Deena Hinshaw, said the woman marks the second case of blood clots and the only death after more than 253,000 doses of AstraZeneca were administered in the province.
Health officials said the benefits of the vaccine outweigh the risk and continue to promote its use. There have been five cases of blood clots reported in the country.
“While any death is tragic, it is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine,” Hinshaw said.
Several countries paused the use of the AstraZeneca vaccine earlier this year after there were reports of blood clots; however, they have since resumed use of the vaccine.